TD Asset Management’s Kymera Therapeutics KYMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
234,970
+32,878
| +16% | +$1.43M | 0.01% | 632 |
|
|
2025
Q1 | $5.53M | Sell |
202,092
-26,468
| -12% | -$724K | 0.01% | 769 |
|
|
2024
Q4 | $9.19M | Buy |
228,560
+21,666
| +10% | +$872K | 0.01% | 667 |
|
|
2024
Q3 | $10.1M | Sell |
206,894
-11,910
| -5% | -$580K | 0.01% | 644 |
|
|
2024
Q2 | $6.53M | Hold |
218,804
| – | – | 0.01% | 700 |
|
|
2024
Q1 | $8.8M | Buy |
218,804
+32,322
| +17% | +$1.3M | 0.01% | 651 |
|
|
2023
Q4 | $4.75M | Buy |
186,482
+2,400
| +1% | +$61.1K | ﹤0.01% | 778 |
|
|
2023
Q3 | $2.56M | Buy |
184,082
+84,167
| +84% | +$1.17M | ﹤0.01% | 889 |
|
|
2023
Q2 | $2.3M | Buy |
99,915
+5,900
| +6% | +$136K | ﹤0.01% | 932 |
|
|
2023
Q1 | $2.79M | Buy |
94,015
+14,500
| +18% | +$430K | ﹤0.01% | 895 |
|
|
2022
Q4 | $1.98M | Buy |
79,515
+900
| +1% | +$22.5K | ﹤0.01% | 991 |
|
|
2022
Q3 | $1.74M | Buy |
78,615
+1,939
| +3% | +$42.8K | ﹤0.01% | 1047 |
|
|
2022
Q2 | $1.51M | Sell |
76,676
-6,786
| -8% | -$134K | ﹤0.01% | 1085 |
|
|
2022
Q1 | $3.53M | Sell |
83,462
-4,858
| -6% | -$206K | ﹤0.01% | 910 |
|
|
2021
Q4 | $5.61M | Buy |
88,320
+20,355
| +30% | +$1.29M | ﹤0.01% | 834 |
|
|
2021
Q3 | $3.99M | Buy |
67,965
+3,300
| +5% | +$194K | ﹤0.01% | 878 |
|
|
2021
Q2 | $3.89M | Buy |
64,665
+38,066
| +143% | +$2.29M | ﹤0.01% | 898 |
|
|
2021
Q1 | $1.03M | Buy |
26,599
+3,598
| +16% | +$140K | ﹤0.01% | 1255 |
|
|
2020
Q4 | $1.43M | Buy |
23,001
+800
| +4% | +$49.6K | ﹤0.01% | 1106 |
|
|
2020
Q3 | $717K | Buy |
+22,201
| New | +$717K | ﹤0.01% | 1155 |
|